GB1569003A - Immunostimulating agent - Google Patents
Immunostimulating agent Download PDFInfo
- Publication number
- GB1569003A GB1569003A GB19294/77A GB1929477A GB1569003A GB 1569003 A GB1569003 A GB 1569003A GB 19294/77 A GB19294/77 A GB 19294/77A GB 1929477 A GB1929477 A GB 1929477A GB 1569003 A GB1569003 A GB 1569003A
- Authority
- GB
- United Kingdom
- Prior art keywords
- neuraminidase
- antigen
- agent
- adjuvant
- units
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2620649A DE2620649C3 (de) | 1976-05-11 | 1976-05-11 | Immunologisches Adjuvans |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1569003A true GB1569003A (en) | 1980-06-11 |
Family
ID=5977559
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB19294/77A Expired GB1569003A (en) | 1976-05-11 | 1977-05-09 | Immunostimulating agent |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4510129A (enExample) |
| JP (1) | JPS52136914A (enExample) |
| AT (1) | AT363590B (enExample) |
| AU (1) | AU512240B2 (enExample) |
| BE (1) | BE854512A (enExample) |
| CA (1) | CA1077841A (enExample) |
| CH (1) | CH630807A5 (enExample) |
| DE (1) | DE2620649C3 (enExample) |
| DK (1) | DK204277A (enExample) |
| FR (1) | FR2350847A1 (enExample) |
| GB (1) | GB1569003A (enExample) |
| IE (1) | IE45145B1 (enExample) |
| IL (1) | IL52048A (enExample) |
| IT (1) | IT1075545B (enExample) |
| LU (1) | LU77295A1 (enExample) |
| NL (1) | NL7704998A (enExample) |
| NZ (1) | NZ184039A (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI790483A7 (fi) * | 1978-02-16 | 1979-08-17 | Science Union & Cie | Foerfarande foer framstaellning av ett enzym av bakteriellt ursprung och farmaceutiska kompositioner innehaollande detsamma |
| US4729893A (en) * | 1984-12-26 | 1988-03-08 | Robert L. Letcher | Enteric encapsulation of ancrod for oral administration |
| GB9018061D0 (en) | 1990-08-17 | 1990-10-03 | Wellcome Found | Compositions for vaccines |
| US20030108927A1 (en) * | 2000-04-03 | 2003-06-12 | Kathryn Leishman | Compositions and methods for the prevention, treatment and detection of tuberculosis and other diseases |
| US7078165B2 (en) * | 2003-03-27 | 2006-07-18 | Institut Pasteur | Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof |
| GB0307989D0 (en) * | 2003-04-07 | 2003-05-14 | Mcewen Lab Ltd | Therapeutic composition |
| EP3741387A1 (en) * | 2012-09-28 | 2020-11-25 | Kline, Ellis | Glycosidase regimen for treatment of infectious disease |
| CN109641038A (zh) | 2016-07-01 | 2019-04-16 | 小利兰·斯坦福大学理事会 | 靶向细胞表面编辑的共轭物 |
| CA3087529A1 (en) | 2018-01-03 | 2019-07-11 | Palleon Pharmaceuticals Inc. | Recombinant human sialidases, sialidase fusion proteins, and methods of using the same |
-
1976
- 1976-05-11 DE DE2620649A patent/DE2620649C3/de not_active Expired
-
1977
- 1977-05-06 CH CH571377A patent/CH630807A5/de not_active IP Right Cessation
- 1977-05-06 NL NL7704998A patent/NL7704998A/xx not_active Application Discontinuation
- 1977-05-09 LU LU77295A patent/LU77295A1/xx unknown
- 1977-05-09 GB GB19294/77A patent/GB1569003A/en not_active Expired
- 1977-05-09 NZ NZ184039A patent/NZ184039A/xx unknown
- 1977-05-09 IL IL52048A patent/IL52048A/xx unknown
- 1977-05-09 IT IT23350/77A patent/IT1075545B/it active
- 1977-05-10 AU AU25033/77A patent/AU512240B2/en not_active Expired
- 1977-05-10 CA CA278,034A patent/CA1077841A/en not_active Expired
- 1977-05-10 FR FR7714243A patent/FR2350847A1/fr active Granted
- 1977-05-10 AT AT0332577A patent/AT363590B/de not_active IP Right Cessation
- 1977-05-10 DK DK204277A patent/DK204277A/da not_active Application Discontinuation
- 1977-05-10 IE IE951/77A patent/IE45145B1/en not_active IP Right Cessation
- 1977-05-11 BE BE177483A patent/BE854512A/xx not_active IP Right Cessation
- 1977-05-11 JP JP5416377A patent/JPS52136914A/ja active Granted
-
1982
- 1982-08-09 US US06/406,531 patent/US4510129A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| FR2350847B1 (enExample) | 1980-02-29 |
| DE2620649B2 (de) | 1980-03-13 |
| IL52048A (en) | 1980-11-30 |
| JPS52136914A (en) | 1977-11-16 |
| NZ184039A (en) | 1980-04-28 |
| ATA332577A (de) | 1981-01-15 |
| JPS624371B2 (enExample) | 1987-01-30 |
| AT363590B (de) | 1981-08-10 |
| IE45145L (en) | 1977-11-11 |
| AU2503377A (en) | 1978-11-16 |
| NL7704998A (nl) | 1977-11-15 |
| AU512240B2 (en) | 1980-10-02 |
| IT1075545B (it) | 1985-04-22 |
| US4510129A (en) | 1985-04-09 |
| CA1077841A (en) | 1980-05-20 |
| IE45145B1 (en) | 1982-06-30 |
| CH630807A5 (de) | 1982-07-15 |
| DK204277A (da) | 1977-11-12 |
| DE2620649C3 (de) | 1980-11-06 |
| FR2350847A1 (fr) | 1977-12-09 |
| DE2620649A1 (de) | 1977-11-17 |
| BE854512A (fr) | 1977-11-14 |
| LU77295A1 (enExample) | 1977-12-13 |
| IL52048A0 (en) | 1977-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU770923B2 (en) | Inactivated influenza virus vaccine for nasal or oral administration | |
| EP0656014B1 (en) | Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition | |
| CS244906B2 (en) | Production method of antigen agent for limitation or prevention of tooth defects | |
| JPH0313205B2 (enExample) | ||
| JPH0561255B2 (enExample) | ||
| GB1569003A (en) | Immunostimulating agent | |
| EP0016755A1 (en) | Neisseria gonorrhoeae vaccine | |
| US4731245A (en) | Vaccine, antigen and antibody for treating microorganisms of the MCLS-type streptococcus sanguis | |
| US3953592A (en) | Live influenza virus vaccines and preparation thereof | |
| US3674863A (en) | Polyvalent immunizing agents and methods for their production | |
| CA1126155A (en) | Immunogenic cell envelope preparations | |
| US5176910A (en) | Treponema hyodysenteriae hemolysin and uses therefor | |
| KR100649286B1 (ko) | 감독화톡신을 포함하는 백신제제 | |
| US4039656A (en) | Production of attenuated viruses | |
| US4049794A (en) | Treatment of infections in animals | |
| EP0721782B1 (en) | Influenza vaccine containing pertussis toxin | |
| Kikuta et al. | Enhancement of DTH response by cholera toxin B subunit inoculated intranasally together with influenza HA vaccine | |
| US3829361A (en) | Method for attenuation of mumps virus | |
| US4017359A (en) | Production of non-antigenic attenuated viruses | |
| US3804713A (en) | Method for the attenuation of rubella virus | |
| Holm et al. | Antigenic composition of a vaccine strain of Francisella tularensis | |
| KITAOKA et al. | Immunological classification of poliomyelitis viruses isolated in Japan | |
| AU681130C (en) | Protein rib, a cell surface protein that confers immunity tomany strains of the group B streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition | |
| KR970010544B1 (ko) | 한탄바이러스 항원과 리켓챠 쯔쯔가무시 항원을 함유하는 혼합항원 조성물 | |
| CN117603317A (zh) | 一种抗中间普氏菌、牙龈卟啉单胞菌和具核羧杆菌复合特异性IgY的制备方法及应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19930509 |